You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
邁瑞醫療(300760.SZ)擬5.45億歐元收購Hytest Invest Oy全部股權 以完善化學發光產品研發及供應鏈平台建設
格隆匯 05-16 17:21

格隆匯5月16日丨邁瑞醫療(300760.SZ)公佈,公司擬通過全資子公司邁瑞全球(香港)有限公司(以下簡稱為“香港全球”)及香港全球的全資子公司Mindray Medical NetherlandsB.V.以現金形式收購以下權益:SummaEquity AB下屬基金和Spartak Co-Investment AB持有的Hytest Invest Oy(以下簡稱“標的公司”)的100%股權;由Maria Severina 和 Alexey Katrukha以及若干自然人股東在標的公司的子公司Hytest Holding Oy中持有的全部少數股權;由MariaSeverina和Jukka Lehikoinen在標的公司的間接子公司Hytest Oy中持有的全部少數股權;以及部分個人股東及自然人持有的Hytest Holding Oy公司4,790,643股期權,從而收購標的公司及其下屬子公司100%股權,收購總價預計約為5.45億歐元,最終交易金額以實際交割時確認為準。

本次交易完成後,公司將間接持有Hytest Invest Oy及其下屬子公司100%的股權。據悉,標的公司主營業務為體外診斷用抗原抗體等試劑原材料的研究、開發、生產、銷售及抗體服務。

公司表示,體外診斷業務是公司的核心發展戰略之一,化學發光產品是公司體外診斷業務的重要分支。為此,公司需進一步加強化學發光產品及原料的核心研發能力建設,優化上下游產業鏈的全球化佈局。本次交易有利於公司更好地整合資源,完善化學發光產品研發及供應鏈平台建設,符合公司長遠發展規劃及全體股東利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account